CUH Logo

Mobile menu open

Professor Ian Wilkinson

Honorary consultant physician (clinical pharmacology/general medicine) and Professor of therapeutics (University of Cambridge, Department of Medicine)

I have over 30 years of clinical experience in investigating and treating high blood pressure (hypertension), with expertise in secondary causes of hypertension, and hypertension in young people and pregnancy.
Ian Wilkinson

If I have seen further it is by standing on the shoulders of Giants.

Sir Isaac Newton

My current role

As president of the British and Irish Hypertension Society, I have led the development of new National Guidelines on hypertension and supported the NHS with public health campaigns and training to ensure more people get diagnosed and treated.

I have also worked with our local ICB to introduce new hypertension guidelines and simplify drug use. My research centres around what causes high blood pressure (hypertension) and how it is best treated.

I have 25 years of research experience and have led several national trials and studies on hypertension. The AIMHY Trial will help define the best treatment for different ethnic groups in the UK, and the POPPY Study will tell us why blood pressure problems in pregnancy increase women’s long-term risk of hypertension and cardiovascular disease.

I deliver outpatient and inpatient specialist hypertension services and also run a joint hypertension service with the Trust department of obstetrics, dealing with all forms of hypertension in pregnancy.

I currently lead the division of Experimental Medicine and Immunotherapeutics (EMIT) at the University of Cambridge, and an active research group focused on hypertension, and cardiovascular physiology and pharmacology. I am leading a number of national trials and studies focused on understanding why people develop hypertension, and what the best treatment is. I also direct the Cambridge Clinical Trials Unit, and the Office of Translational Research.

I provide undergraduate teaching in pharmacology and physiology and also examine for pharmacology. At Trinity Hall, I Chair the Property Investments, Buildings, and Audit Committees and supervise for MODA.

Since 2019, I have had the honour of serving as a non-executive director at Royal Papworth Hospital.  

I am currently President of the British and Irish Hypertension Society, and also provide specialist hypertension advice to NHSE and the Cardiovascular Prevention Leadership group.

Previous history

My undergraduate training was in Oxford and house jobs in Oxford and Nottingham.

I completed my specialist training in clinical pharmacology/general medicine in Oxford and Edinburgh and took up a University lectureship/hon consultant physician in Cambridge in 2000.

I have previously held a British Heart Foundation senior clinical research fellowship and been a NIHR senior investigator for 8 years.

Membership and accreditations

  • Fellow Trinity Hall Cambridge
  • Director of Cambridge Clinical Trials Unit
  • President of the British and Irish Hypertension Society
  • Fellow British Society of Pharmacology
  • Fellow Royal College of Physicians London and Edinburgh
  • NIHR Senior Investigator